WHO ICTRP trial
Intralymphatic immunotherapy for house dust mite allergic rhinitis, a pilot…
TCTR20220725001 · Thai Clinical Trials Registry (TCTR) · Recruiting
Key facts
| Trial ID | TCTR20220725001 |
|---|---|
| Public title | Intralymphatic immunotherapy for house dust mite allergic rhinitis, a pilot study |
| Scientific title | Intralymphatic immunotherapy for house dust mite allergic rhinitis, a pilot study |
| Primary sponsor | Phramongkutklao hospital |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 1/Phase 2 |
| Countries | Thailand |
| Conditions | Allergic rhinitis Allergic rhinitis Allergic specific immunotherapy Intralymphatic immunotherapy ILIT House dust mite allergy Dysfunctional regulatory T cell;Allergic rhinitis Allergic specific immunotherapy Intralymphatic immunotherapy… |
| Interventions | Intralymphatic house dust mite allergen specific immunotherapy at inguinal lymph node Total 3 doses with 1 month interval 1st dose: 10 AU/0.1 ml, 2nd dose: 50 AU/0.1ml, 3rd dose: 150 AU/0.1 ml;Experimental Biological/Vaccine;Intralymphatic… |
| Registration date | Jul 25, 2022 |
| Target size | 6 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: